[ad_1]
A The American pharmaceutical company Pfizer and the German biotechnology company BioNTech revealed on Monday that their novel coronavirus vaccine showed more than 90% efficacy among those without evidence of infection front.
According to Reuters, faced with this news, Anthony Maw, director American Institute of Contagious Diseases, said in statements to the CNN, that the United States could have doses of the vaccine ready to give to people by the end of the year.
The results released today correspond to the first evaluation of the Phase 3 trial of clinical trials, the last before the request for approval by the health authorities.
This effectiveness of protection to the virus SARS–CoV-2 was reached seven days after the second vaccine dose and 28 days after the first.
In the same interview, Maw he said he believes it will continue into current location and who has no intention of leaving. It is recalled that Donald Trump – who tries to contest the outcome of the US elections, the results of which give the victory to Joe Biden – has already criticized the epidemiologist several times.
Always be the first to know.
Follow the site chosen for the fourth consecutive year Consumer Choice.
Download our free App.
.
[ad_2]
Source link
